Du J, Gu J, Li J (2020) Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels. Biosci Rep. https://doi.org/10.1042/bsr20200401

Okusaka T, Furuse J (2020) Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines. J Gastroenterol 55:369–382. https://doi.org/10.1007/s00535-020-01666-y

Article  PubMed  PubMed Central  Google Scholar 

Binenbaum Y, Na’ara S, Gil Z (2015) Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug Resist Updat 23:55–68. https://doi.org/10.1016/j.drup.2015.10.002

Article  PubMed  Google Scholar 

Wang S, Li Y, Xing C et al (2020) Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer. Am J Cancer Res 10:1937–1953

CAS  PubMed  PubMed Central  Google Scholar 

Jordheim LP, Sève P, Trédan O et al (2011) The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer. Lancet Oncol 12:693–702. https://doi.org/10.1016/s1470-2045(10)70244-8

Article  CAS  PubMed  Google Scholar 

Kato T, Ono H, Fujii M et al (2021) Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. PLoS ONE 16:e0252917. https://doi.org/10.1371/journal.pone.0252917

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, Zhang L, Zheng H et al (2020) Identification of chemoresistance-related mRNAs based on gemcitabine-resistant pancreatic cancer cell lines. Cancer Med 9:1115–1130. https://doi.org/10.1002/cam4.2764

Article  CAS  PubMed  Google Scholar 

Mesmar F, Dai B, Ibrahim A et al (2019) Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signaling. Cancer Med 8:7705–7719. https://doi.org/10.1002/cam4.2581

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dillies MA, Rau A, Aubert J et al (2013) A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief Bioinform 14:671–683. https://doi.org/10.1093/bib/bbs046

Article  CAS  PubMed  Google Scholar 

Ritchie ME, Phipson B, Wu D et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https://doi.org/10.1093/nar/gkv007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li A, He J, Zhang Z et al (2021) Integrated bioinformatics analysis reveals marker genes and potential therapeutic targets for pulmonary arterial hypertension. Genes (Basel). https://doi.org/10.3390/genes12091339

Article  PubMed  PubMed Central  Google Scholar 

Bai R, Li Z, Hou Y et al (2021) Identification of diagnostic markers correlated with HIV(+) immune non-response based on bioinformatics analysis. Front Mol Biosci 8:809085. https://doi.org/10.3389/fmolb.2021.809085

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu G, Wang LG, Han Y et al (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284–287. https://doi.org/10.1089/omi.2011.0118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szklarczyk D, Gable AL, Lyon D et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607-d613. https://doi.org/10.1093/nar/gky1131

Article  CAS  PubMed  Google Scholar 

Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504. https://doi.org/10.1101/gr.1239303

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chin CH, Chen SH, Wu HH et al (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(Suppl 4):S11. https://doi.org/10.1186/1752-0509-8-s4-s11

Article  PubMed  PubMed Central  Google Scholar 

Tang Z, Li C, Kang B et al (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98-w102. https://doi.org/10.1093/nar/gkx247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin L, Li W, Xu A et al (2020) SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway. EBioMedicine 51:102596. https://doi.org/10.1016/j.ebiom.2019.12.005

Article  PubMed  PubMed Central  Google Scholar 

Tan Y, Li X, Tian Z et al (2021) TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Biochem Pharmacol 189:114085. https://doi.org/10.1016/j.bcp.2020.114085

Article  CAS  PubMed  Google Scholar 

Qiu W, Su GH (2013) Development of orthotopic pancreatic tumor mouse models. Methods Mol Biol 980:215–223. https://doi.org/10.1007/978-1-62703-287-2_11

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shakeel S, Finley C, Akhtar-Danesh G et al (2020) Trends in survival based on treatment modality in patients with pancreatic cancer: a population-based study. Curr Oncol 27:e1–e8. https://doi.org/10.3747/co.27.5211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim MP, Gallick GE (2008) Gemcitabine resistance in pancreatic cancer: picking the key players. Clin Cancer Res 14:1284–1285. https://doi.org/10.1158/1078-0432.Ccr-07-2247

Article  CAS  PubMed  Google Scholar 

Fu X, Deng X, Xiao W et al (2021) Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis. Am J Cancer Res 11:3841–3856

CAS  PubMed  PubMed Central  Google Scholar 

Huber M, Brehm CU, Gress TM et al (2020) The immune microenvironment in pancreatic cancer. Int J Mol Sci. https://doi.org/10.3390/ijms21197307

Article  PubMed  PubMed Central  Google Scholar 

Li TJ, Wang WQ, Yu XJ et al (2020) Killing the “BAD”: challenges for immunotherapy in pancreatic cancer. Biochim Biophys Acta Rev Cancer 1874:188384. https://doi.org/10.1016/j.bbcan.2020.188384

Article  CAS  PubMed  Google Scholar 

Bhatia R, Bhyravbhatla N, Kisling A et al (2022) Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment. Semin Cancer Biol 86:499–510. https://doi.org/10.1016/j.semcancer.2022.03.021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berberat PO, Dambrauskas Z, Gulbinas A et al (2005) Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 11:3790–3798. https://doi.org/10.1158/1078-0432.Ccr-04-2159

Article  CAS  PubMed  Google Scholar 

Kemp SB, Carpenter ES, Steele NG et al (2021) Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-κB-mediated production of CXCL1. Cancer Res 81:4305–4318. https://doi.org/10.1158/0008-5472.Can-20-3929

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bent EH, Gilbert LA, Hemann MT (2016) A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes Dev 30:1811–1821. https://doi.org/10.1101/gad.284851.116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu QB, Wan MY, Wang PY et al (2018) Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade. Redox Biol 14:656–668. https://doi.org/10.1016/j.redox.2017.11.012

Article  CAS  PubMed  Google Scholar 

Akita H, Zheng Z, Takeda Y et al (2009) Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma. Oncogene 28:2903–2909. https://doi.org/10.1038/onc.2009.158

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisher SB, Patel SH, Bagci P et al (2013) An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment. Cancer 119:445–453. https://doi.org/10.1002/cncr.27619

Article  CAS  PubMed  Google Scholar 

Elander NO, Aughton K, Ghaneh P et al (2018) Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. Br J Cancer 118:1084–1088. https://doi.org/10.1038/s41416-018-0005-1

Article  CAS  PubMed